News – Page 30 – Endpoints News

Paratek boosts commercial portfolio in move to buy Optinose and its nasal spray

2 months ago

Sanofi to pay $600M upfront for Dren Bio’s bispecific B cell depleter

2 months ago

A California health tech company is letting AI run medical visits, from intake to diagnosis

2 months ago

Novartis touts Zolgensma data in older kids as it readies regulatory filings

2 months ago

Gilead stock slips as HHS denies reports of HIV funding cuts

2 months ago

DOJ lawyers defend abortion pill restrictions in new court filing

2 months ago

Cargo Therapeutics scraps R&D pipeline, axes bulk of workforce as it looks for an exit

2 months ago

Ahead of FDA decision, Alnylam faces the big question: Can it make money?

2 months ago

Regenxbio shares new Duchenne gene therapy data ahead of big readout next year

2 months ago

Pfizer fully exits Sensodyne maker Haleon in $3.3B stake sale

2 months ago

Updated: Immunovant will not take rare disease drug to regulators despite Phase 3 win

2 months ago

Roche inks $1B+ biobucks deal with UK biotech for new antibody cancer targets

2 months ago

Flagship's Ampersand gets Eli Lilly's support in $65M Series B

2 months ago

Servier pays $70M upfront for Black Diamond’s RAS- and RAF-targeted cancer drug

2 months ago

Stem cell company bit.bio cuts quarter of staff, drops therapeutics focus

2 months ago

HHS keeps probationary workers on administrative leave after court order

2 months ago

Empress Therapeutics confirms layoffs; Nanobiotix amends J&J deal terms

2 months ago

Stoke CEO Ed Kaye to depart shortly after inking Biogen pact and before its first Phase 3 trial

2 months ago

Sixteen-year-old dies after receiving Sarepta’s Duchenne gene therapy

2 months ago

Exclusive: Foodsmart names former Amwell executive as its new CEO

2 months ago

A Japanese biotech founded by Treg cell discoverer moves to the US with $45.8M

2 months ago

Updated: Novartis revamps cardiovascular commercial strategy as Entresto patent cliff looms

2 months ago

CRISPR company Arbor raises $73.9M to test therapy in clinical trials

2 months ago

Sofinnova Partners lands €165M, backed by big pharma, to build early-stage biotechs in Europe

2 months ago

First page Previous page 27 28 293031 32 33 Next page Last page